Prosight Management, LP Quant / Systematic

Location: Dallas, TX

CIK: 0001617201 · Show all filings

Period: Q1 2020 (← Previous) (Next →)

Filing Date: May 15, 2020

Total Value: $214M (100.0% shares, 0.0% debt)

Holdings (44)

ARENA PHARMACEUTICALS INC 8.2%
Value $17.62M Shares 419,602 Est. Cost $43.41 Unrealized
IOVA IOVANCE BIOTHERAPEUTICS INC 7.7%
Value $16.56M Shares 553,100 Est. Cost $16.88 Unrealized +57.1%
KURA KURA ONCOLOGY INC 6.7%
Value $14.43M Shares 1,450,000 Est. Cost $14.92 Unrealized -23.3%
ALEXION PHARMACEUTICALS INC 5.9%
Value $12.57M Shares 140,000 Est. Cost $89.79 Unrealized
QURE UNIQURE NV 5.4%
Value $11.65M Shares 245,564 Est. Cost $59.81 Unrealized -3.9%
REATA PHARMACEUTICALS INC 5.1%
Value $10.83M Shares 75,000 Est. Cost $62.08 Unrealized
ZBH ZIMMER BIOMET HOLDINGS INC 5.0%
Value $10.61M Shares 105,000 Est. Cost $110.07 Unrealized +13.4%
UTHR UNITED THERAPEUTICS CORP DEL 4.2%
Value $8.914M Shares 94,000 Est. Cost $82.53 Unrealized +15.2%
CNC CENTENE CORP DEL 4.0%
Value $8.455M Shares 142,308 Est. Cost $55.81 Unrealized +8.7%
CUE CUE BIOPHARMA INC 3.7%
Value $7.834M Shares 552,060 Est. Cost $14.74 Unrealized +9.6%
MGTX MEIRAGTX HOLDINGS PLC 3.6%
Value $7.639M Shares 568,348 Est. Cost $20.76 Unrealized -18.6%
DIREXION SHS ETF TR 3.5%
Value $7.425M Shares 125,000 Est. Cost $59.40 Unrealized
ACIU AC IMMUNE SA 3.4%
Value $7.316M Shares 1,058,697 Est. Cost $5.81 Unrealized +34.5%
CI CIGNA CORP NEW 3.1%
Value $6.579M Shares 37,129 Est. Cost $178.01 Unrealized -0.3%
CHANGE HEALTHCARE INC 2.6%
Value $5.586M Shares 559,125 Est. Cost $9.99 Unrealized
ALBIREO PHARMA INC 2.5%
Value $5.409M Shares 330,407 Est. Cost $26.28 Unrealized
ALDX ALDEYRA THERAPEUTICS INC 2.3%
Value $5.027M Shares 2,035,340 Est. Cost $6.60 Unrealized -31.9%
LHC GROUP INC 2.3%
Value $4.894M Shares 34,909 Est. Cost $140.19 Unrealized
AMN AMN HEALTHCARE SVCS INC 2.3%
Value $4.825M Shares 83,471 Est. Cost $68.44 Unrealized 0.0%
ZOGENIX INC 1.9%
Value $4.048M Shares 163,708 Est. Cost $24.73 Unrealized
ADMA ADMA BIOLOGICS INC 1.7%
Value $3.579M Shares 1,242,700 Est. Cost $3.46 Unrealized 0.0%
PSNL PERSONALIS INC 1.6%
Value $3.347M Shares 414,740 Est. Cost $14.02 Unrealized -33.7%
ARWR ARROWHEAD PHARMACEUTICALS IN 1.4%
Value $3.013M Shares 104,737 Est. Cost $40.33 Unrealized 0.0%
EHC ENCOMPASS HEALTH CORP 1.4%
Value $3.003M Shares 46,900 Est. Cost $53.73 Unrealized 0.0%
URGN UROGEN PHARMA LTD 1.2%
Value $2.608M Shares 146,179 Est. Cost $38.49 Unrealized -29.8%
ORGO ORGANOGENESIS HLDGS INC 1.0%
Value $2.171M Shares 672,275 Est. Cost $6.17 Unrealized -30.6%
EOLS EVOLUS INC 1.0%
Value $2.134M Shares 514,206 Est. Cost $11.07 Unrealized -23.4%
BMRN BIOMARIN PHARMACEUTICAL INC 0.9%
Value $1.935M Shares 22,900 Est. Cost $85.05 Unrealized +1.3%
IMVT IMMUNOVANT INC 0.9%
Value $1.89M Shares 121,429 Est. Cost $11.17 Unrealized +34.7%
ESTA ESTABLISHMENT LABS HLDGS INC 0.9%
Value $1.83M Shares 126,658 Est. Cost $22.07 Unrealized 0.0%
CATALYST BIOSCIENCES INC 0.8%
Value $1.673M Shares 382,900 Est. Cost $9.00 Unrealized
ABBV ABBVIE INC 0.6%
Value $1.221M Shares 16,030 Est. Cost $67.19 Unrealized 0.0%
ANAB ANAPTYSBIO INC 0.5%
Value $1.116M Shares 78,976 Est. Cost $23.65 Unrealized -35.9%
CHANGE HEALTHCARE INC 0.5%
Value $999K Shares 100,000 Est. Cost Unrealized
NVST ENVISTA HOLDINGS CORPORATION 0.4%
Value $867K Shares 58,000 Est. Cost $28.45 Unrealized -10.0%
LGND LIGAND PHARMACEUTICALS INC 0.4%
Value $836K Shares 11,500 Est. Cost $56.68 Unrealized 0.0%
HCA HCA HEALTHCARE INC 0.4%
Value $829K Shares 9,223 Est. Cost $123.42 Unrealized 0.0%
APOLLO ENDOSURGERY INC 0.3%
Value $648K Shares 337,262 Est. Cost $2.36 Unrealized
NSP INSPERITY INC 0.2%
Value $481K Shares 12,900 Est. Cost $60.03 Unrealized 0.0%
KEZAR LIFE SCIENCES INC 0.2%
Value $421K Shares 96,615 Est. Cost $4.01 Unrealized
STEALTH BIOTHERAPEUTICS CORP 0.2%
Value $417K Shares 336,167 Est. Cost $1.24 Unrealized
EVOLUS INC 0.1%
Value $306K Shares 73,700 Est. Cost Unrealized
THC TENET HEALTHCARE CORP 0.1%
Value $301K Shares 20,918 Est. Cost $28.71 Unrealized 0.0%
MIST MILESTONE PHARMACEUTICALS IN 0.0%
Value $77,000 Shares 41,592 Est. Cost $17.73 Unrealized -2.4%